يعرض 1 - 20 نتائج من 2,576 نتيجة بحث عن '(( significantly ((nn decrease) OR (point decrease)) ) OR ( significant benefits decrease ))', وقت الاستعلام: 0.32s تنقيح النتائج
  1. 1

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

    منشور في 2025
    "…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
  2. 2

    Summary map of all contacts with statistically significant SVM classifications. حسب Alexander P. Rockhill (6053618)

    منشور في 2024
    "…Yellow reflects high classification accuracy, while dark blue represents less robust classification accuracy. Time-frequency points with no significant classification value are white.…"
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Summary statistics of key variables. حسب Saul Estrin (8629173)

    منشور في 2024
    "…We propose that, while there are still agglomeration benefits, the development path followed by cities in developing countries also creates significant agglomeration costs and these act to limit innovation. …"
  11. 11
  12. 12

    Raw data. حسب Saeedeh Abbasi (9423189)

    منشور في 2025
    الموضوعات:
  13. 13

    Data. حسب Saeedeh Abbasi (9423189)

    منشور في 2025
    الموضوعات:
  14. 14
  15. 15

    Point cloud fusion instance effect. حسب Hongliang Zou (20707270)

    منشور في 2025
    الموضوعات:
  16. 16

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"
  17. 17

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"
  18. 18

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"
  19. 19
  20. 20